Cuu Long Pharmaceutical JSC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DCL1
VND
41,850.00
-3150 (-7.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

  • INTEREST(HY) At VND 26,426.22 MM has Grown at 111.64%
  • ROCE(HY) Lowest at 2.35%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 2.05 times
2

With ROE of 2.84%, it has a expensive valuation with a 1.43 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND 3,973,432 Million (Small Cap)

stock-summary
P/E

50.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.35

stock-summary
Return on Equity

2.36%

stock-summary
Price to Book

2.65

Revenue and Profits:
Net Sales:
372,593 Million
(Quarterly Results - Dec 2025)
Net Profit:
3,793 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.29%
0%
-10.29%
6 Months
41.86%
0%
41.86%
1 Year
97.41%
0%
97.41%
2 Years
63.16%
0%
63.16%
3 Years
87.67%
0%
87.67%
4 Years
20.09%
0%
20.09%
5 Years
46.33%
0%
46.33%

Cuu Long Pharmaceutical JSC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
16.25%
EBIT Growth (5y)
10.79%
EBIT to Interest (avg)
2.58
Debt to EBITDA (avg)
0.80
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
0.60
Tax Ratio
23.88%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.46%
ROE (avg)
6.63%

Valuation key factors

Factor
Value
P/E Ratio
50
Industry P/E
Price to Book Value
1.43
EV to EBIT
39.07
EV to EBITDA
23.58
EV to Capital Employed
1.32
EV to Sales
1.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.38%
ROE (Latest)
2.84%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -26.98% vs 31.15% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -80.11% vs -34.12% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "372,593.20",
          "val2": "510,263.20",
          "chgp": "-26.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26,091.30",
          "val2": "31,759.30",
          "chgp": "-17.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "12,573.20",
          "val2": "6,024.00",
          "chgp": "108.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,793.20",
          "val2": "19,071.40",
          "chgp": "-80.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.90%",
          "val2": "43.50%",
          "chgp": "-1.06%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 1.13% vs 14.24% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -62.89% vs -12.86% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,321,589.10",
          "val2": "1,306,797.40",
          "chgp": "1.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "111,901.40",
          "val2": "98,087.70",
          "chgp": "14.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "49,128.60",
          "val2": "25,494.50",
          "chgp": "92.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "20,091.20",
          "val2": "54,145.50",
          "chgp": "-62.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "44.30%",
          "val2": "45.80%",
          "chgp": "-0.15%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
372,593.20
510,263.20
-26.98%
Operating Profit (PBDIT) excl Other Income
26,091.30
31,759.30
-17.85%
Interest
12,573.20
6,024.00
108.72%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3,793.20
19,071.40
-80.11%
Operating Profit Margin (Excl OI)
32.90%
43.50%
-1.06%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is -26.98% vs 31.15% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -80.11% vs -34.12% in Dec 2024

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,321,589.10
1,306,797.40
1.13%
Operating Profit (PBDIT) excl Other Income
111,901.40
98,087.70
14.08%
Interest
49,128.60
25,494.50
92.70%
Exceptional Items
0.00
0.00
Consolidate Net Profit
20,091.20
54,145.50
-62.89%
Operating Profit Margin (Excl OI)
44.30%
45.80%
-0.15%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 1.13% vs 14.24% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -62.89% vs -12.86% in Dec 2024

stock-summaryCompany CV
About Cuu Long Pharmaceutical JSC stock-summary
stock-summary
Cuu Long Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Cuu Long Pharmaceutical Joint Stock Corporation (Pharimexco) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, markets and distributes pharmaceutical drugs and capsules, as well as medical equipment and supplies. It is also involved in the manufacture and trading of functional food, cosmetic products, chemicals and other materials for pharmaceutical production. Other activities include the manufacture of specialized packagings for drugs and medical products, as well as the cultivation of traditional herbs.
Company Coordinates stock-summary
Company Details
So 150 duong 14/9, phuong 5 , VINH LONG None : None
stock-summary
Tel: 84 27 0382253384 70 3822533
stock-summary
Registrar Details